Asthma Inhaler Access and Price Caps
In 2024, major asthma inhaler manufacturers, including AstraZeneca, Boehringer Ingelheim, and GSK, announced $35 monthly caps on out-of-pocket costs for select inhalers. The price caps apply to individuals with commercial/private insurance or no insurance. AstraZeneca's and Boehringer Ingelheim's caps went into effect in June 2024, and GSK's caps became effective this month.
More information about the inhaler price caps and how to access each manufacturer's savings program can be found here: What You Need to Know About the $35 Price Cap on Asthma Inhalers | Asthma and Allergy Foundation of America